COVID-19: towards understanding of pathogenesis

doi:10.1038/s41422-020-0327-4

Comment

. 2020 May;30(5):367-369.

doi: 10.1038/s41422-020-0327-4.

COVID-19: towards understanding of pathogenesis

Wei Cao¹, Taisheng Li²

Affiliations

¹ Department of Infectious Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, 1# Shuai Fu Yuan, Dongcheng District, Beijing, 100730, China.
² Department of Infectious Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, 1# Shuai Fu Yuan, Dongcheng District, Beijing, 100730, China. litsh@263.net.

PMID: 32346073
PMCID: PMC7186532
DOI: 10.1038/s41422-020-0327-4

Comment

COVID-19: towards understanding of pathogenesis

Wei Cao et al. Cell Res. 2020 May.

. 2020 May;30(5):367-369.

doi: 10.1038/s41422-020-0327-4.

Authors

Wei Cao¹, Taisheng Li²

Affiliations

¹ Department of Infectious Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, 1# Shuai Fu Yuan, Dongcheng District, Beijing, 100730, China.
² Department of Infectious Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, 1# Shuai Fu Yuan, Dongcheng District, Beijing, 100730, China. litsh@263.net.

PMID: 32346073
PMCID: PMC7186532
DOI: 10.1038/s41422-020-0327-4

No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

**Fig. 1. Hypothetical pathogenesis of COVID-19.**
The X-axis refers to days after SARS-CoV-2 infection. The disease course is divided into three phases. The Y-axis shows the trend of T cells, B cells, inflammatory factors, D-dimer and viral load in patients. a The trend of each indicator in severe COVID-19 patients. b The trend of each indicator in severe COVID-19 patients after low-molecular-weight heparin (LWMH) and high-dose intravenous immunoglobulin (IVIg) therapy. The shaded areas represent the recommended intervention time for LMWH and IVIg treatment.

See this image and copyright information in PMC

Comment on

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.
Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B, Zhu N, Bi Y, Ma X, Zhan F, Wang L, Hu T, Zhou H, Hu Z, Zhou W, Zhao L, Chen J, Meng Y, Wang J, Lin Y, Yuan J, Xie Z, Ma J, Liu WJ, Wang D, Xu W, Holmes EC, Gao GF, Wu G, Chen W, Shi W, Tan W. Lu R, et al. Lancet. 2020 Feb 22;395(10224):565-574. doi: 10.1016/S0140-6736(20)30251-8. Epub 2020 Jan 30. Lancet. 2020. PMID: 32007145 Free PMC article.

Cited by

A Journey From SARS-CoV-2 to COVID-19 and Beyond: A Comprehensive Insight of Epidemiology, Diagnosis, Pathogenesis, and Overview of the Progress into Its Therapeutic Management.
Shoaib MH, Ahmed FR, Sikandar M, Yousuf RI, Saleem MT. Shoaib MH, et al. Front Pharmacol. 2021 Feb 26;12:576448. doi: 10.3389/fphar.2021.576448. eCollection 2021. Front Pharmacol. 2021. PMID: 33732150 Free PMC article. Review.
COVID-19 vaccine research and development: ethical issues.
Wibawa T. Wibawa T. Trop Med Int Health. 2021 Jan;26(1):14-19. doi: 10.1111/tmi.13503. Epub 2020 Oct 19. Trop Med Int Health. 2021. PMID: 33012020 Free PMC article. Review.
Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications.
Merrill JT, Erkan D, Winakur J, James JA. Merrill JT, et al. Nat Rev Rheumatol. 2020 Oct;16(10):581-589. doi: 10.1038/s41584-020-0474-5. Epub 2020 Jul 30. Nat Rev Rheumatol. 2020. PMID: 32733003 Free PMC article. Review.
Long COVID Definition, Symptoms, Risk Factors, Epidemiology and Autoimmunity: A Narrative Review.
Kozłowski P, Leszczyńska A, Ciepiela O. Kozłowski P, et al. Am J Med Open. 2024 Feb 14;11:100068. doi: 10.1016/j.ajmo.2024.100068. eCollection 2024 Jun. Am J Med Open. 2024. PMID: 39034937 Free PMC article.
Toll-Like Receptors (TLRs) as Therapeutic Targets for Treating SARS-CoV-2: An Immunobiological Perspective.
Patra R, Das NC, Mukherjee S. Patra R, et al. Adv Exp Med Biol. 2021;1352:87-109. doi: 10.1007/978-3-030-85109-5_6. Adv Exp Med Biol. 2021. PMID: 35132596

See all "Cited by" articles

References

1. Lu R, et al. Lancet. 2020;395:565–574. doi: 10.1016/S0140-6736(20)30251-8. - DOI - PMC - PubMed
1. Wölfel, R. et al. Nature10.1038/s41586-020-2196-x (2020). - PubMed
1. Qin, C. et al. Clin. Infect. Dis. 10.1093/cid/ciaa248 (2020). - PubMed
1. Zhou F, et al. Lancet. 2020;395:1054–1062. doi: 10.1016/S0140-6736(20)30566-3. - DOI - PMC - PubMed
1. Xu Z, et al. Lancet Respir. Med. 2020;8:420–422. doi: 10.1016/S2213-2600(20)30076-X. - DOI - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources

[1] Lu R, et al. Lancet. 2020;395:565–574. doi: 10.1016/S0140-6736(20)30251-8. - DOI - PMC - PubMed

[2] Lu R, et al. Lancet. 2020;395:565–574. doi: 10.1016/S0140-6736(20)30251-8. - DOI - PMC - PubMed

[3] Wölfel, R. et al. Nature10.1038/s41586-020-2196-x (2020). - PubMed

[4] Wölfel, R. et al. Nature10.1038/s41586-020-2196-x (2020). - PubMed

[5] Qin, C. et al. Clin. Infect. Dis. 10.1093/cid/ciaa248 (2020). - PubMed

[6] Qin, C. et al. Clin. Infect. Dis. 10.1093/cid/ciaa248 (2020). - PubMed

[7] Zhou F, et al. Lancet. 2020;395:1054–1062. doi: 10.1016/S0140-6736(20)30566-3. - DOI - PMC - PubMed

[8] Zhou F, et al. Lancet. 2020;395:1054–1062. doi: 10.1016/S0140-6736(20)30566-3. - DOI - PMC - PubMed

[9] Xu Z, et al. Lancet Respir. Med. 2020;8:420–422. doi: 10.1016/S2213-2600(20)30076-X. - DOI - PMC - PubMed

[10] Xu Z, et al. Lancet Respir. Med. 2020;8:420–422. doi: 10.1016/S2213-2600(20)30076-X. - DOI - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

COVID-19: towards understanding of pathogenesis

Affiliations

COVID-19: towards understanding of pathogenesis

Authors

Affiliations

Conflict of interest statement

Figures

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Conflict of interest statement

Figures

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

Related information

LinkOut - more resources

Full Text Sources